To address this, we utilized computational approaches to identify NK1R antagonists with alternative structural features, evaluated their antidepressant-like effects in preclinical models of depression using behavioral assessments and analyzed markers of neuroinflammation at the mRNA level. This evidence concerns the gene TACR1 and major depressive disorder.